Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 158 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

4 Weeks Treatment of Type II Diabetic Patients With BI 44847

NCT00558909

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • 1224.4.49002 Boehringer Ingelheim Investigational Site Berlin, Germany
  • 1224.4.49003 Boehringer Ingelheim Investigational Site Mainz, Germany
  • 1224.4.49001 Boehringer Ingelheim Investigational Site Neuss, Germany
  • 1224.4.31001 Boehringer Ingelheim Investigational Site Zuidlaren, Netherlands
View Trial Details
Completed

Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes

NCT01215955

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Concord, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fresno, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lakewood, California, United States
View all 76 locations
View Trial Details
Completed

A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients

NCT01280695

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Goodyear, Arizona, United States
  • Chula Vista, California, United States
  • Los Angeles, California, United States
  • Bradenton, Florida, United States
View all 14 locations
View Trial Details
Completed

Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure

NCT01117350

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Investigational Site Number 840023 Birmingham, Alabama, United States
  • Investigational Site Number 840002 Goodyear, Arizona, United States
  • Investigational Site Number 840047 Phoenix, Arizona, United States
  • Investigational Site Number 840017 La Jolla, California, United States
View all 136 locations
View Trial Details

Related conditions